Literature DB >> 23982701

Overexpression of heparanase in ovarian cancer and its clinical significance.

Wei Zhang1, Hong Chan, Louwei Wei, Zhongmian Pan, Jieqing Zhang, Li Li.   

Abstract

It has been reported that heparanase (HPSE) is overexpressed in ovarian cancer and is associated with tumor invasion and metastasis. However, a systematic study on the contribution of HPSE to tumor metastasis is rarely reported. In this study, based on the measurement of HPSE serum concentration, the expression of HPSE at both the mRNA and protein levels in tumors and its effects on the biological behaviors of cancer cells, we elucidated the role of HPSE in tumor invasion and metastasis in ovarian cancer and concluded that either the expression of HPSE in cancer and/or the serum concentration of HPSE may be a useful biomarker for the evaluation of surgery effects and prognosis prediction.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23982701     DOI: 10.3892/or.2013.2701

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  5 in total

1.  MicroRNA-219a-2-3p modulates the proliferation of thyroid cancer cells via the HPSE/cyclin D1 pathway.

Authors:  Chuanjia Yang; Siyang Zhang; Xiaoying Chang; Yonglian Huang; Dongxu Cui; Zhen Liu
Journal:  Exp Ther Med       Date:  2021-04-20       Impact factor: 2.447

2.  Diagnostic Performance of Serum Human Epididymis Protein 4 in Endometrial Carcinoma: A Pilot Study.

Authors:  Rupali Dewan; Abhinav Dewan; Swati Hare; Mausumi Bhardwaj; Krati Mehrotra
Journal:  J Clin Diagn Res       Date:  2017-07-01

Review 3.  Roles of Proteoglycans and Glycosaminoglycans in Cancer Development and Progression.

Authors:  Jinfen Wei; Meiling Hu; Kaitang Huang; Shudai Lin; Hongli Du
Journal:  Int J Mol Sci       Date:  2020-08-20       Impact factor: 5.923

4.  Hallmarks of glycogene expression and glycosylation pathways in squamous and adenocarcinoma cervical cancer.

Authors:  Patricia Martinez-Morales; Irene Morán Cruz; Lorena Roa-de la Cruz; Paola Maycotte; Juan Salvador Reyes Salinas; Victor Javier Vazquez Zamora; Claudia Teresita Gutierrez Quiroz; Alvaro Jose Montiel-Jarquin; Verónica Vallejo-Ruiz
Journal:  PeerJ       Date:  2021-08-31       Impact factor: 2.984

5.  Impact of Adjuvant Treatment on Heparanase Concentration in Invasive, Unilateral Breast Cancer Patients: Results of a Prospective Single-Centre Cohort Study.

Authors:  Barbara Ruszkowska-Ciastek; Kornel Bielawski; Elżbieta Zarychta; Piotr Rhone
Journal:  J Clin Med       Date:  2021-05-18       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.